電話

Consultation Info.:049-228-3411

Number Info.:049-228-3400

▶Contact information

Department of Urology

February 12,2021 Update

Introduction

Urologists treat a wide range of organs, from those along the urinary tract (kidneys, ureters, bladder, and urethra) to the male reproductive organs (prostate, testes, epididymis, penis, and scrotum) to the adrenal glands that produce hormones. There is a wide variety of conditions that affect these organs and systems, including cancer, infectious diseases, calculus, urination disorders, urinary incontinence, and testicular torsion, which requires emergency surgery. There are also many treatment options, including drug therapy, radiotherapy, and surgery.

At the Department of Urology at the Saitama Medical Center, we conduct medical treatment to support all urological diseases. We have obtained many positive outcomes for patients with renal cancer through surgery and medication. We also have had good outcomes for patients with upper urinary tract cancers, including renal pelvis cancer, ureteral cancer, and bladder cancer, using a combination of drug therapy, radiotherapy, and surgical therapies.

Customized treatments are developed for patients with prostate cancer according to their age and the clinical stage of the disease. Our radiation therapy plans include not only normal external irradiation but also intensity modulated radiation therapy (IMRT) and high dose rate brachytherapy (HDR). We continue to develop minimally invasive surgeries for all kinds of urological diseases, including percutaneous and transurethral surgery for urolithiasis and minimum incision endoscopic surgery for malignant tumors.

We provide prompt treatment for testicular torsion patients to preserve the testes, and we perform autologous midurethral sling surgery for stress urinary incontinence using the patient's own fascia, which prevents complications caused by artificial materials such as mesh.

Medical care is progressing and constantly evolving. We provide compassionate care to patients with urological conditions and diseases, and we constantly strive to identify and implement best practices, utilizing the most current research available.

Patient care at our department

The Department of Urology is responsible for the management of urological diseases in general. In particular, we are working on professional and advanced treatment for the three pillars of urological diseases: urological malignancy, urolithiasis, and dysuria.

We place emphasis on radical cure for the treatment of urological malignancy. In addition to open surgery, we also perform minimum incision endoscopic surgery (MIES). In addition to conventional standard therapies, we also incorporate the latest treatments such as immune checkpoint inhibitors (Nivolumab, Ipilimumab, Pembrolizumab) for metastatic kidney cancer and metastatic urinary tract cancer and Radium-223 treatment for bony metastasis of prostate cancer. Furthermore, we can perform unique multimodal treatments, such as a low-volume cisplatin based chemoradiotherapy with partial resection of the bladder for invasive bladder cancer, and high dose rate radiation therapy (HDR) for local progressive prostate cancer in cooperation with the Department of Radiation Oncology.

For urolithiasis, we can choose the treatment that best suits the patient's condition. For example, we may use a combination of the two surgeries, transurethral ureterolithotripsy and percutaneous nephrolithotomy (Endoscopic Combined IntraRenal Surgery: ECIRS), or the extracorporeal shock wave lithotripsy (ESWL) technique.

For dysuria caused by prostatic hyperplasia or neurogenic bladder, we are able to fully understand the condition through ultrasonic examination and urodynamics examination, after which we perform surgery and administer drug therapy. In the past, we have performed the modified autologos midurethral sling surgery (Yamada procedure), developed in our department, for stress urinary incontinence in women. This treatment provides the option of treatment without using artificial mesh materials.

The outpatient clinic is available Monday to Saturday and closed on Sunday and public holidays. If you are a first visit patient, please complete the reception process between 8:30 am and 11:00 am. Please be aware that we do not accept any new patients without a referral letter. Thank you very much for your understanding.

If you are currently taking any medications, please bring them or a medication record book so that we can have a clear understanding of what you are taking.

Contact information for the outpatient clinic:
Department of Urology Tel. 049-228-3672

Main diseases

  • Kidney cancer
  • Renal pelvic cancer
  • Ureteral cancer
  • Prostate cancer
  • Pheochromocytoma
  • Primary hyperaldosteronism
  • Cushing's syndrome
  • Adrenal cancer
  • Bladder cancer
  • Testicular cancer
  • Penile cancer
  • Benign prostatic hyperplasia
  • Testicular torsion
  • Nephrolithiasis
  • Ureterolithiasis
  • Bladder calculous
  • Urethral stenosis
  • Stress urinary incontinence
  • Overactive bladder
  • Interstitial cystitis
  • Hydrocele testis
  • Penile fracture
  • Priapism
  • Pyelonephritis
  • Cystitis
  • Pyonephrosis
  • Epididymitis
  • Prostatitis
  • Urethritis
  • Torsion of the appendix testis
  • Pyourachus
  • Hydronephrosis
 

Target Symptoms

  • Hematuria
  • Painful urination
  • Hypogastric pain
  • Lower back pain
  • Difficulty urinating
  • Frequent urination
  • Urinary urgency
  • Incomplete emptying
  • Incontinence
  • Scrotal swelling
  • Scrotum pain
  • Hematospermia
 

Treatment results

2019
Total number of surgeries (excluding ESWL and prostate biopsies) 725
Major surgical procedure
Nephrectomy 27
Partial nephrectomy 10
Nephroureterectomy 23
Total cystectomy 18
Transurethral resection of bladder tumor (TURBT) 174
Radical retropubic prostatectomy (RRP) 41
Adrenalectomy 9
Transurethral resection of the prostate (TURP) 15
Percutaneous nephrolithotomy (PNL) 4
Transurethral ureterolithotripsy (TUL) 85
ECIRS(PNL+TUL) 7
High Orchiectomy 6
Testicular torsion surgery 9
Female urinary incontinence surgery 5
Nephrostomy Percutaneous 59

Medical staff

Name Job Title Position Specialized Field Credentials
川上 理
(Kawakami Satoru)
泌尿器科スタッフ002
Professor Chief of Clinical Services Prostate cancer
Genitourinary cancer
Japanese Board Certified Urologist/Instructor
General Clinical Oncologist (by JBCT)
Board Certified Member of Japanese Society of Minimum Incision Endoscopic Urological Surgery
諸角 誠人
(Morozumi Makoto)
泌尿器科スタッフ001
Director of Kidney stone center,Associate Professor Chief Administrator
Genitourinary cancer
Testicular cancer
Urinary stone sugery
Japanese Board Certified Urologist/Instructor
General Clinical Oncologist (by JBCT)
Board Certified Endocrinologist (by JES)
矢野 晶大
(Yano Akihiro)
泌尿器科スタッフ009
Associate Professor Manager of General Affairs
Chief of Researcher
Prostate cancer
Genitourinary cancer
Japanese Board Certified Urologist/Instructor
General Clinical Oncologist (by JBCT)
JSE certified laparoscopic surgeon
岡田 洋平
(Okada Youhei)
泌尿器科スタッフ003
Assistant Professor Manager of Outpatient Services
Chief of Education
Genitourinary cancer
Transuretheral endoscopic surgery
Japanese Board Certified Urologist/Instructor
General Clinical Oncologist (by JBCT)
Board Certified Member of Japanese Society of Minimum Incision Endoscopic Urological Surgery
竹下 英毅
(Takeshira Hideki)
泌尿器科スタッフ004
Assistant Professor Manager of Inpatient Services Genitourinary cancer
Dysuria
Acute scrotum
Japanese Board Certified Urologist/Instructor
General Clinical Oncologist (by JBCT)
中山 貴之
Nakayama Takayuki
泌尿器科スタッフ010
Instructor Genitourinary cancer
Tumor immunology
Japanese Board Certified Urologist/Instructor
Board Certified Member of Japanese Society of Minimum Incision Endoscopic Urological Surgery
香川 誠
(Kagawa Makoto)
泌尿器科スタッフ006
Instructor Genitourinary cancer Japanese Board Certified Urologist/Instructor
General Clinical Oncologist (by JBCT)
立花 康次郎
(Tachibana Koujirou)
泌尿器科スタッフ009
Instructor General urology
Urinary stone sugery
梅澤 佑太
(Umezawa Yuta)
泌尿器科スタッフ009
Resident General urology
杉山 博紀
(Sugiyama Hironori)
泌尿器科スタッフ007
on loan General urology
Urinary stone sugery
Japanese Board Certified Urologist

Outpatient clinic

Department of Urology
  Monday Tuesday Wednesday Thursday Friday Saturday
午前
初診
(交替制)
(交替制)
(交替制)
(交替制)
(交替制)
(交替制)
再診
竹下 英毅
(Takeshita Hideki)
香川 誠
(Kagawa Makoto)
矢野 晶大
(Yano Akihiro)
岡田 洋平
(Okada Yohei)
立花 康次郎
(Tachibana Kojiro)

中山 貴之
(Nakayama Takayuki)
諸角 誠人
(Morozumi Makoto)
川上 理
(Kawakami Satoru)
川上 理
(Kawakami Satoru)
諸角 誠人
(Morozumi Makoto)

初診の患者さんは紹介状の持参をお願いします。

To the Medical Institutions

To the medical students and residents
With the rapid aging of the population, there is a growing need for urologists to treat malignant tumors, urinary tract stones, dysuria, and among others. Based on a variety of clinical cases in our department, we aim to advance the comprehensive clinical ability of our urologists, which are translatable anywhere in the world. In addition, we aim to foster a 'Scientific Surgeon' who can conduct clinical research that is useful to patients.
Our strengths:
  • Kawagoe is the third largest city in Saitama Prefecture and has recently been attracting the attention of foreigners and tourists. As we are a core university hospital in the region, many patients can visit us and benefit from a wide range of medical experiences.
  • Since we are a comprehensive medical center, we practice a wide range of treatments.
  • In addition to our surgery treatment options, we have staff who are friendly and helpful and are willing to assist even with academic presentations and thesis preparation.

If you are a resident or medical student who is interested in clinical urology, please feel free to contact us at this department (Chief Okada: okada@saitama-med.ac.jp). Given the lack of manpower that we often experience here in Kawagoe, we encourage the addition of hardworking persons. You are, of course, welcome to come on board after the completion of your training.

Presentations for academic societies and papers in our department in recent years:
We study new tumor markers for prostate cancer, urinary tract cancer, and renal cancer and conduct original clinical research on unknown characteristics of testicular torsion. We have launched a joint research collaboration with the Division of Gene Regulation and Signal Transduction, Saitama Medical University Research Center for Genomic Medicine, and we strive to provide novel results that are translatable and useful to patients.
In addition, our young medical staff have conducted several case reports from our extensive clinical cases. We also offer training for academic presentations and writing papers.
埼玉医科大学バナー 埼玉医科大学看護学校バナー